BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 37749638)

  • 1. CHSY1 promotes CD8
    Sun G; Zhao S; Fan Z; Wang Y; Liu H; Cao H; Sun G; Huang T; Cai H; Pan H; Rong D; Gao Y; Tang W
    J Exp Clin Cancer Res; 2023 Sep; 42(1):248. PubMed ID: 37749638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MGP promotes CD8
    Rong D; Sun G; Zheng Z; Liu L; Chen X; Wu F; Gu Y; Dai Y; Zhong W; Hao X; Zhang C; Pan X; Tang J; Tang W; Wang X
    Int J Biol Sci; 2022; 18(6):2345-2361. PubMed ID: 35414780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CHSY1 is upregulated and acts as tumor promotor in gastric cancer through regulating cell proliferation, apoptosis, and migration.
    Liu J; Tian Z; Liu T; Wen D; Ma Z; Liu Y; Zhu J
    Cell Cycle; 2021 Sep; 20(18):1861-1874. PubMed ID: 34412565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cholesterol induction in CD8
    Shuwen H; Yinhang W; Jing Z; Qiang Y; Yizhen J; Quan Q; Yin J; Jiang L; Xi Y
    Cancer Immunol Immunother; 2023 Dec; 72(12):4441-4456. PubMed ID: 37919522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CHSY1 promotes aggressive phenotypes of hepatocellular carcinoma cells via activation of the hedgehog signaling pathway.
    Liu CH; Lan CT; Chou JF; Tseng TJ; Liao WC
    Cancer Lett; 2017 Sep; 403():280-288. PubMed ID: 28652022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NF-κB Activator 1 downregulation in macrophages activates STAT3 to promote adenoma-adenocarcinoma transition and immunosuppression in colorectal cancer.
    Wang S; Kuai Y; Lin S; Li L; Gu Q; Zhang X; Li X; He Y; Chen S; Xia X; Ruan Z; Lin C; Ding Y; Zhang Q; Qi C; Li J; He X; Pathak JL; Zhou W; Liu S; Wang L; Zheng L
    BMC Med; 2023 Mar; 21(1):115. PubMed ID: 36978108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanism of Bazhen decoction in the treatment of colorectal cancer based on network pharmacology, molecular docking, and experimental validation.
    Lu S; Sun X; Zhou Z; Tang H; Xiao R; Lv Q; Wang B; Qu J; Yu J; Sun F; Deng Z; Tian Y; Li C; Yang Z; Yang P; Rao B
    Front Immunol; 2023; 14():1235575. PubMed ID: 37799727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TGF-β Induces Up-Regulation of Chondroitin Sulfate Synthase 1 (CHSY1) in Nucleus Pulposus Cells Through MAPK Signaling.
    Hu B; Shi C; Tian Y; Zhang Y; Xu C; Chen H; Cao P; Yuan W
    Cell Physiol Biochem; 2015; 37(2):793-804. PubMed ID: 26356269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LINC01296/miR-26a/GALNT3 axis contributes to colorectal cancer progression by regulating O-glycosylated MUC1 via PI3K/AKT pathway.
    Liu B; Pan S; Xiao Y; Liu Q; Xu J; Jia L
    J Exp Clin Cancer Res; 2018 Dec; 37(1):316. PubMed ID: 30547804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Liposome nanoparticles for targeted delivery of parthenolide induce colorectal cancer necroptosis to ameliorate tumor-infiltrating T cell exhaustion in mice].
    Yao W; Wang X; Yang Y; You J; Jin J; Zeng P; Han Q; Yao X; Sun X; Zhou J
    Nan Fang Yi Ke Da Xue Xue Bao; 2023 Oct; 43(10):1674-1681. PubMed ID: 37933642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD8
    Viot J; Abdeljaoued S; Vienot A; Seffar E; Spehner L; Bouard A; Asgarov K; Pallandre JR; Renaude E; Klajer E; Molimard C; Monnien F; Bibeau F; Turco C; Heyd B; Peixoto P; Hervouet E; Loyon R; Doussot A; Borg C; Kroemer M
    Cell Mol Immunol; 2023 Apr; 20(4):365-378. PubMed ID: 36717657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chsy1 deficiency reduces extracellular matrix productions and aggravates cartilage injury in osteoarthritis.
    Lyu Z; Da Y; Liu H; Wang Z; Zhu Y; Tian J
    Gene; 2022 Jun; 827():146466. PubMed ID: 35390446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TOX promotes the exhaustion of antitumor CD8
    Wang X; He Q; Shen H; Xia A; Tian W; Yu W; Sun B
    J Hepatol; 2019 Oct; 71(4):731-741. PubMed ID: 31173813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting CD43 optimizes cancer immunotherapy through reinvigorating antitumor immune response in colorectal cancer.
    Li YY; Wang XY; Li Y; Wang XM; Liao J; Wang YZ; Hong H; Yi W; Chen J
    Cell Oncol (Dordr); 2023 Jun; 46(3):777-791. PubMed ID: 36920728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PLOD3 facilitated T cell activation in the colorectal tumor microenvironment and liver metastasis by the TNF-α/ NF-κB pathway.
    Ding M; Wang C; Hu J; She J; Shi R; Liu Y; Sun Q; Xu H; Zhou G; Wu W; Xia H
    J Transl Med; 2024 Jan; 22(1):30. PubMed ID: 38184566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unveiling YWHAH: A potential therapeutic target for overcoming CD8
    Li Q; Yuan Z; Wang Y; Zhai P; Wang J; Zhang C; Shao Z; Xing C
    Int Immunopharmacol; 2024 Jun; 135():112317. PubMed ID: 38796965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single-cell analysis revealed a potential role of T-cell exhaustion in colorectal cancer with liver metastasis.
    Ling T; Zhang C; Liu Y; Jiang C; Gu L
    J Cell Mol Med; 2024 Apr; 28(8):e18341. PubMed ID: 38647235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of Chondroitin Sulfate Modification Causes Inflammation and Neurodegeneration in
    Macke EL; Henningsen E; Jessen E; Zumwalde NA; Landowski M; Western DE; Lee WH; Liu C; Gruenke NP; Doebley AL; Miller S; Pattnaik B; Ikeda S; Gumperz JE; Ikeda A
    Genetics; 2020 Jan; 214(1):121-134. PubMed ID: 31754016
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Organ-specific cholesterol metabolic aberration fuels liver metastasis of colorectal cancer.
    Zhang KL; Zhu WW; Wang SH; Gao C; Pan JJ; Du ZG; Lu L; Jia HL; Dong QZ; Chen JH; Lu M; Qin LX
    Theranostics; 2021; 11(13):6560-6572. PubMed ID: 33995676
    [No Abstract]   [Full Text] [Related]  

  • 20. LncRNA
    Xu YJ; Zhao JM; Ni XF; Wang W; Hu WW; Wu CP
    Epigenomics; 2021 Aug; 13(16):1281-1297. PubMed ID: 34523356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.